Page last updated: 2024-11-01

nimodipine and Adiadochokinesis

nimodipine has been researched along with Adiadochokinesis in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fletcher, CF1
Tottene, A1
Lennon, VA1
Wilson, SM1
Dubel, SJ1
Paylor, R1
Hosford, DA1
Tessarollo, L1
McEnery, MW1
Pietrobon, D1
Copeland, NG1
Jenkins, NA1

Other Studies

1 other study available for nimodipine and Adiadochokinesis

ArticleYear
Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:7

    Topics: Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, N-Type; Calcium Channels, P-T

2001